Investment Rating - The report assigns a "Neutral" rating with a total score of 69 out of 100 [3][14]. Core Insights - The company has a promising pipeline with products that, if approved, could meet significant demand in the Chinese market, particularly for conditions like Pediatric Growth Hormone Deficiency (PGHD) and Hypoparathyroidism [2][8][10]. - The company is positioned as the first endocrine drug manufacturer in the Hong Kong market, which may provide a competitive edge [14]. Industry Outlook - PGHD is prevalent among children under 18, accounting for 41.5% of short stature cases in China, with only 5.3% treatment rate in 2023, indicating a substantial unmet need [2]. - The market for achondroplasia treatment is currently limited, with only two products in clinical trials, suggesting a strong first-mover advantage for the company's product, Navepegritide [6]. - The demand for drugs treating Hypoparathyroidism is expected to grow, with the patient population projected to increase from 410,100 in 2023 to 495,600 by 2030 [7]. Company Operations - The company has not yet launched any products, resulting in no sales revenue. The net loss for shareholders in 2023 was approximately 250 million RMB, a 13.5% reduction year-on-year [8]. - Research and development costs have decreased significantly, contributing to the reduced net loss, while cash flow from operating activities remains healthy with no bank loans [8]. - The company has a robust pipeline with core products already approved in Europe and the U.S., with expectations for approval in China by 2025 [5][10]. Valuation Level - The company's valuation is considered reasonable, with a market capitalization range of 77.0 to 84.6 billion HKD, slightly lower than comparable companies in the biotech sector [10][12]. - The price-to-book ratio for the company's IPO price is estimated at 18.3 to 20.2 times, which is competitive compared to peers [10]. Market Sentiment - The recent market atmosphere has improved, with a higher percentage of newly listed companies experiencing price increases on their debut [13]. - The presence of notable cornerstone investors, such as WuXi Biologics, indicates confidence in the company's research capabilities [14].

Investment Rating - The report maintains a "Buy" rating for the company [1][5] Core Views - The company achieved a significant improvement in profitability in 2024, with total revenue reaching USD 10.259 billion, a year-on-year increase of 15.9%, driven by strong global parcel volume growth [8] - Adjusted EBITDA rose to USD 778 million, reflecting a substantial increase of 430.5%, indicating enhanced profitability [8] - The company turned a profit with a net income of USD 114 million in 2024, compared to a loss of USD 1.156 billion in 2023 [8] - The report highlights the continued improvement in domestic business profitability and the ongoing increase in overseas market share [5] Financial Performance Summary - The company’s revenue is projected to grow from RMB 63.056 billion in 2023 to RMB 109.376 billion by 2027, with a compound annual growth rate (CAGR) of approximately 13% [7] - The adjusted EBITDA is expected to improve significantly from a loss of RMB 4.107 billion in 2023 to a profit of RMB 11.567 billion by 2027 [7] - The net profit is forecasted to increase from a loss of RMB 7.845 billion in 2023 to RMB 6.341 billion by 2027, representing a growth rate of 240.1% in 2025 [7] - Earnings per share (EPS) are expected to rise from a loss of RMB 0.88 in 2023 to RMB 0.71 by 2027 [7] Market and Operational Insights - The company’s global parcel volume reached 24.65 billion pieces in 2024, marking a year-on-year growth of 31.0% [8] - The Southeast Asia market remains a core area, with parcel volume reaching 4.56 billion pieces and a market share increase to 28.6% [8] - In China, parcel volume reached 19.8 billion pieces, with a market share of 11.3%, ranking sixth in the industry [8] - The company has made strategic price adjustments to expand its market share in Southeast Asia, which has slightly impacted single-ticket revenue but has improved cost efficiency [8]

Investment Rating - The report maintains an "Outperform" rating for the company, with a target price of 82.62 HKD based on a 2025 PE of 25X [2][9]. Core Insights - Miu Miu's retail revenue grew by 93% in 2024, with EBIT margin reaching a 10-year high. Overall revenue increased by 14.9% YoY to 5.43 billion Euros, while net profit rose by 25% YoY to 839 million Euros [2][9]. - The company is expected to continue its strong growth trajectory, with net profit forecasts of 972 million Euros, 1.088 billion Euros, and 1.191 billion Euros for 2025-2027, representing growth rates of 15.9%, 11.9%, and 9.5% respectively [2][9]. Financial Data and Forecasts - Key financial metrics for the company include: - Revenue (million Euros): 2023: 4726, 2024: 5432, 2025E: 6059, 2026E: 6646, 2027E: 7207 [2][6]. - Net Profit (million Euros): 2023: 671, 2024: 839, 2025E: 972, 2026E: 1088, 2027E: 1191 [2][6]. - Gross Margin (%): 2024: 79.84%, 2025E: 79.80%, 2026E: 79.90%, 2027E: 80.00% [2][6]. - Return on Equity (%): 2024: 19.07%, 2025E: 19.84%, 2026E: 19.93%, 2027E: 19.63% [2][6]. Retail Performance and Strategy - The retail network optimization is evident, with a slight decrease in the number of direct stores to 609, and a net opening of 3 stores. The company plans to continue retail investments and expand Miu Miu into new markets [2][9]. - Retail revenue growth in 2024 was notable across regions, with Asia-Pacific, Europe, Americas, Japan, and the Middle East showing growth rates of 13%, 18%, 9%, 46%, and 26% YoY respectively [2][9]. Management Changes - Miu Miu appointed Silvia Onofri as the new CEO, who has extensive experience in the luxury sector, previously holding positions at Bulgari and Bally [2][9].

Investment Rating - The investment rating for the company is "Outperform" [5][14]. Core Insights - The report highlights that the company's gross profit margin remains robust at 60.2% for Q4, with expectations for revenue growth to improve in Q1 2025 [7][14]. - The company has announced a buyback plan, reflecting long-term confidence in its performance [2][14]. - The overall revenue for 2024 is projected to decline by 2.5% to USD 3.59 billion, with a slight recovery expected in 2025 [7][14]. Financial Data and Forecasts - **Revenue Forecast**: - 2023: USD 3,682 million - 2024: USD 3,589 million - 2025E: USD 3,743 million - 2026E: USD 3,928 million - 2027E: USD 4,118 million - Year-over-year growth rates show a decline of 2.5% in 2024, followed by modest growth in subsequent years [4][11]. - **Net Profit Forecast**: - 2023: USD 417 million - 2024: USD 346 million - 2025E: USD 382 million - 2026E: USD 413 million - 2027E: USD 440 million - The net profit margin is expected to recover gradually after a decline in 2024 [4][11]. - **Earnings Per Share (EPS)**: - 2023: USD 0.29 - 2024: USD 0.24 - 2025E: USD 0.26 - 2026E: USD 0.28 - 2027E: USD 0.30 [4][11]. - **Gross Margin**: - 2023: 59.3% - 2024: 60.0% - 2025E: 60.0% - 2026E: 60.1% - 2027E: 60.2% [4][11]. - **Return on Equity (ROE)**: - 2023: 28.8% - 2024: 23.4% - 2025E: 20.6% - 2026E: 18.2% - 2027E: 16.2% [4][11]. Market Performance - The company's stock closed at HKD 19.10, with a 52-week price range of HKD 16.78 to HKD 31.60 [5][14]. - The total market capitalization is approximately HKD 27,930 million [5][14]. Revenue Performance by Region - Q4 2024 revenue showed a slight decline of 0.1% year-over-year, with a currency-neutral increase of 1% [7][14]. - Revenue changes in Q4 2024 by region were as follows: - Asia: -6.3% - North America: +3.9% - Europe: +5.6% - Latin America: +14% [7][14]. Cash Flow and Dividends - Adjusted free cash flow increased by 9.3% to USD 310 million [7][14]. - Total dividends for the year were USD 150 million, with a payout ratio of 43.4% [7][14].

Investment Rating - The report maintains an "Outperform" rating for Haitian International [2] Core Views - Haitian International achieved a revenue of RMB 16.13 billion in 2024, representing a year-on-year increase of 23.4%, with a net profit of RMB 3.08 billion, up 23.6% year-on-year [3][11] - The company is focused on enhancing its global market share through multi-dimensional market strategies and active globalization efforts [5][14] - The target price is set at HKD 26.3, with a projected P/E ratio of 12 for 2025 [5][15] Revenue and Profit Growth - The company reported a gross margin of 32.5% for 2024, an increase of 0.4 percentage points from the previous year, driven by lower raw material prices and improved economies of scale [3][11] - In the second half of 2024, revenue reached RMB 8.11 billion, a 21.2% increase year-on-year, with net profit attributable to shareholders of RMB 1.56 billion, up 26.4% year-on-year [3][11] Regional Performance - Domestic revenue for 2024 was RMB 10.11 billion, a 27.7% increase year-on-year, while overseas revenue was RMB 6.02 billion, up 16.8% year-on-year [4][12] - The company experienced significant growth in the Mars and Zhafir series of injection molding machines, benefiting from demand recovery in consumer goods and home appliances [4][13] Future Outlook - The company plans to continue benefiting from the recovery of global manufacturing and domestic consumption demand, aiming to expand into both mature and emerging markets [5][14] - Factories in Japan and Serbia are expected to be completed in 2025, enhancing the localization of the supply chain [5][14] Earnings Forecast and Valuation - The revenue forecast for 2025 is RMB 17.1 billion, with a net profit of RMB 3.24 billion, and for 2026, revenue is projected at RMB 15.8 billion with a net profit of RMB 2.88 billion [5][15]

Investment Rating - The report maintains a "Buy" rating for China Tower (0788.HK) [3]. Core Views - The company's performance is driven by its "One Body, Two Wings" strategy, leading to steady growth and an increased focus on shareholder returns through a higher dividend payout ratio [1]. - In 2024, the company reported a revenue of RMB 97.772 billion, a year-on-year increase of 4.0%, with a net profit of RMB 10.729 billion, reflecting a 10% growth [1]. - The EBITDA for 2024 reached RMB 66.559 billion, up 4.7%, with an EBITDA margin of 68.1% [1]. Summary by Sections Revenue and Profitability - The operator business generated revenue of RMB 84.119 billion, growing by 2.4%, while the two wings business saw revenue of RMB 13.388 billion, up 16.4% [1]. - The company achieved a significant improvement in cash flow, with operating cash flow of RMB 49.468 billion, a year-on-year increase of RMB 16.628 billion [1]. Operator Business - The tower business revenue was RMB 75.689 billion, a 0.9% increase, with the number of tower sites increasing to 2.094 million [1]. - The indoor distribution business revenue reached RMB 8.430 billion, growing by 18.1%, with significant expansions in coverage areas [1]. Two Wings Business - The smart connection business generated RMB 8.911 billion, a 22.4% increase, focusing on sectors like emergency services and agriculture [1]. - The energy business revenue was RMB 4.477 billion, up 6.2%, while the battery swap business revenue reached RMB 2.5 billion, growing by 20.9% [1]. Shareholder Returns - The company increased its dividend payout ratio, distributing a total dividend of RMB 0.41696 per share for 2024, an 11.5% increase from 2023 [1]. - The depreciation and amortization as a percentage of revenue decreased from 52.2% in 2023 to 51.4% in 2024, indicating effective investment management [1]. Profit Forecast and Valuation - The net profit forecast for 2025 and 2026 has been adjusted downwards by 10% and 14% to RMB 11.726 billion and RMB 18.123 billion, respectively, with a new forecast for 2027 at RMB 19.2 billion [1]. - The report emphasizes the potential for significant profit growth in 2026 due to the expiration of certain tower depreciations [1].

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company is a leading global garment manufacturer with a diversified product range, including casual wear, denim, intimate apparel, knitwear, sportswear, and outdoor clothing. It has established a strong customer base and is expanding into the sports sector, which is expected to enhance growth potential [3][5][36]. - The company has a stable revenue and profit trajectory, with a projected increase in net profit from 1.41 billion RMB in 2024 to 1.95 billion RMB in 2026, reflecting a compound annual growth rate (CAGR) of 19% [1][15]. - The global apparel market is expected to grow steadily, with the sportswear segment projected to reach a retail market size of $407.42 billion by 2024, growing at a CAGR of 6.2% from 2014 to 2024 [26][28]. Company Overview - The company was founded in 1970 and is headquartered in Hong Kong, operating approximately 20 factories across Vietnam, China, Cambodia, Bangladesh, and Sri Lanka, with an annual production capacity exceeding 470 million pieces [5][6]. - The company has a concentrated ownership structure, with the founders holding 76.5% of the shares, ensuring stable control [12]. Financial Performance - In 2023, the company reported revenues of $2.177 billion, a decrease of 12.6% year-on-year, with a net profit of $164 million, down 5.3% year-on-year. However, the company is entering a recovery phase, with a projected revenue growth of 8.4% in the first half of 2024 [15][26]. - The company maintains a stable gross margin of around 19-20% since 2018, with net profit margins expected to improve due to operational efficiencies and cost control measures [16][20]. Industry Analysis - The global apparel industry is projected to reach a retail market size of $1.45 trillion by 2024, with a CAGR of 3.0% from 2014 to 2024. The sportswear segment is expected to grow significantly, indicating a favorable market environment for the company [26][28]. - The concentration of brands in the sportswear segment is significantly higher than in other categories, with the top 10 brands expected to account for 42.3% of the market by 2024 [28][31]. Strategic Focus - The company emphasizes a diversified product portfolio and a collaborative model with clients, enhancing customer loyalty and operational efficiency. It serves over 50 brands, including Uniqlo, H&M, and Gap, with a focus on expanding its sportswear client base [36][41]. - The company is actively pursuing vertical integration by acquiring upstream suppliers, which is expected to improve delivery capabilities and profitability [36][7].

Investment Rating - The report maintains a "Buy" rating for the company and raises the target price to HKD 9.1, indicating a potential upside of 19% from the current price of HKD 7.63 [1][3]. Core Insights - The company focuses on high-quality revenue growth, strategically emphasizing high-end camera module projects, which is expected to lead to significant profit improvements in the second half of 2024 [7]. - The fundamental growth trend is anticipated to continue into 2025, driven by a doubling of shipments for mobile periscope modules, rapid growth in ultrasonic fingerprint recognition modules, and ongoing expansion in automotive and drone sectors [7]. - The company has shown strong performance in controlling expenses, resulting in a net profit increase of 168% year-on-year for 2024 [7]. Financial Forecasts - Revenue is projected to grow from RMB 12,531 million in 2023 to RMB 20,974 million by 2027, with a compound annual growth rate (CAGR) of approximately 8% [2]. - Net profit is expected to rise significantly from RMB 82 million in 2023 to RMB 667 million in 2027, reflecting a robust growth trajectory [2]. - The gross margin is forecasted to improve from 4.1% in 2023 to 7.0% in 2027, indicating enhanced profitability [2]. Performance Metrics - For the second half of 2024, the company anticipates a revenue of RMB 84.8 billion, a year-on-year increase of 20%, with a gross margin of 6.9% [7]. - The company expects that by 2025, at least 55% of mobile module shipments will be 32 million pixels or higher, with a significant increase in sales of fingerprint modules and automotive IoT modules [7]. - The average selling price of camera modules is projected to increase, contributing to overall revenue growth [7]. Valuation - The report employs a sum-of-the-parts valuation method, assigning target price-to-earnings (P/E) ratios of 15.0x for mobile camera modules, 18.0x for other camera modules, and 20.0x for fingerprint recognition modules, leading to a target price of HKD 9.1 [7][15].

Investment Rating - The report assigns a "Buy" rating for the company, indicating a potential upside of 15% to 35% [5][10]. Core Insights - The company has unveiled a humanoid robot prototype capable of various actions, showcasing its innovation in robotics [5]. - The company has a strong foundation in the robotics industry, having entered the industrial robotics sector in 2015 and acquired KUKA, a leading global manufacturer [6]. - The company is integrating resources to develop humanoid robots, focusing on key components such as gear reducers, motors, sensors, and controllers [6]. - Recent government policies are expected to support the home appliance sector, with a significant increase in funding for consumer goods upgrades [6]. - Profit forecasts for the company indicate net profits of RMB 39.06 billion, RMB 44.05 billion, and RMB 49.11 billion for 2024, 2025, and 2026 respectively, with year-on-year growth rates of 15.8%, 12.8%, and 11.5% [6]. Financial Summary - The company's revenue is projected to grow from RMB 373.71 billion in 2023 to RMB 442.58 billion in 2025 [12]. - The earnings per share (EPS) are expected to increase from RMB 4.93 in 2023 to RMB 6.32 in 2025 [5][12]. - The dividend per share (DPS) is forecasted to rise from RMB 3.00 in 2023 to RMB 3.79 in 2025, with a dividend yield exceeding 4% [5][12].

Investment Rating - The investment rating for the company is "Buy" [7] Core Views - The company reported a revenue of $3.6 billion for 2024, a year-on-year decrease of 2.5%, but a slight decline of 0.2% when excluding foreign exchange impacts. Adjusted EBITDA was $680 million, down 3.7% year-on-year, and net profit attributable to shareholders was $350 million, down 12.9% year-on-year. In Q4 alone, revenue reached $940 million, a year-on-year decrease of 0.6%, with adjusted EBITDA of $190 million, up 7.7% year-on-year, and net profit of $110 million, up 22.7% year-on-year [1][5][12]. Summary by Sections Revenue Performance - In Q4, North America, Europe, and China saw positive revenue growth, while India and South Korea experienced declines, leading to a 7% year-on-year drop in Asian revenue. Specifically, revenue from China was $70 million (up 2%), India $50 million (down 28%), Japan $50 million (up 3%), and South Korea $30 million (down 17%). North America generated $350 million (up 4%), with the U.S. contributing $330 million (up 4%). Europe achieved $210 million (up 5%), with Belgium at $60 million (up 16%) and Germany at $30 million (down 7%) [2][3]. Brand and Channel Performance - In Q4, the brands TUMI and Samsonite saw revenue growth, with TUMI at $250 million (up 4%) and Samsonite at $480 million (up 3%). The DTC (Direct-to-Consumer) channel showed stable performance, with revenues of $280 million (up 0.1%) and $130 million (up 1.2%) for DTC self-operated and DTC e-commerce channels, respectively. The company plans to open 67 new stores, increasing the total to 1,119, demonstrating confidence in growth despite a weak retail environment [3][4]. Profitability and Margins - The gross margin for Q4 was 60.2%, an increase of 0.3 percentage points year-on-year, attributed to higher-end brand performance and discount control. The adjusted EBITDA margin reached 20.7%, a historical high, while the net profit margin was 12.2%, down 3.5 percentage points year-on-year due to a high base from previous impairment reversals [4][5]. Earnings Forecast and Valuation - The company is expected to achieve revenues of $3.7 billion, $3.8 billion, and $3.9 billion for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 1.8%, 4.1%, and 3.5%. Net profit attributable to shareholders is projected to be $370 million, $410 million, and $460 million for the same years, with growth rates of 6.2%, 10.8%, and 12.8%. The price-to-earnings ratio is estimated to be 10, 9, and 8 times for the respective years [5][12][13].